Coloplast A/S (CPH:COLO.B)
Denmark
· Delayed Price · Currency is DKK 551.40
+0.80 (0.15%)
Sep 29, 2025, 4:59 PM CET
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2013 - 2019 |
| Ostomy Care | 9.55B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ostomy Care Growth | 5.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Continence Care | 8.54B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Continence Care Growth | 7.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Interventional Urology | 2.78B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Interventional Urology Growth | 2.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Wound Dressings | 3.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Wound Dressings Growth | -21.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Voice and Respiratory Care | 2.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Voice and Respiratory Care Growth | 8.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biologics | 1.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biologics Growth | 50.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2013 - 2019 |
| Chronic Care Segment EBIT | 10.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chronic Care Segment EBIT Growth | 5.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Interventional Urology Segment EBIT | 976.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Interventional Urology Segment EBIT Growth | -0.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Wound Dressings Segment EBIT | 1.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Wound Dressings Segment EBIT Growth | -0.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | -6.10B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 6.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Voice and Respiratory Care Segment EBIT | 736.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Voice and Respiratory Care Segment EBIT Growth | 11.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biologics Segment EBIT | 101.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biologics Segment EBIT Growth | 58.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2013 - 2019 |
| European Markets | 14.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| European Markets Growth | 4.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Developed Markets | 7.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Developed Markets Growth | 8.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Emerging Markets | 4.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Emerging Markets Growth | 4.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2013 - 2019 |
| Ostomy Care Organic Growth | 7.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Continence Care Organic Growth | 8.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Wound Care Organic Growth | 10.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Interventional Urology Organic Growth | 5.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Organic Growth | 8.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Voice and Respiratory Care Organic Growth | 11.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|